Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions

Standard

Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions. / Turner, Daniel; Basdekis-Jozsa, Raphaela; Dekker, Arne; Briken, Peer.

in: WORLD J BIOL PSYCHIA, Jahrgang 15, Nr. 6, 2014, S. 472-478.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

APA

Vancouver

Bibtex

@article{36feedc637e7421f8f2c59fe7259321c,
title = "Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions",
abstract = "Objectives. Although testosterone-lowering medications (TLM) are a frequently used addition to psychotherapy in sex offender treatment, discord still seems to exist amongst clinicians as to in which cases administering TLM is justified. The depo-Provera scale (DPS), which was published by Maletzky and Field (Aggress Violent Behav 2003;8:391), assesses the appropriateness of TLM administration in sex offender treatment. Methods. The DPS was sent to all forensic psychiatric institutions in Germany. The clinical directors of these institutions were asked to rate the importance of each item of the DPS on a six-point Likert scale. Results. Twenty-nine clinicians participated. The most important reason selected for the prescription of TLM for sex offender treatment was a {"}history of sexual offender treatment failure{"}. The least important item was {"}deviant sexual interest, by plethysmograph or Abel Screen{"} (neither plethysmograph nor Abel Screen is used in Germany). Conclusions. Clinicians' attitudes towards the DPS correspond to the suggestions made in the current WSFBF-guidelines for the pharmacological treatment of sex offenders ( Thibaut et al. 2010 ; World J Biol Psychiatry 11:604-655). Use of the DPS could therefore contribute to a more structured approach towards helping clinicians come to a decision about whether or not to treat a sex offender with TLM.",
author = "Daniel Turner and Raphaela Basdekis-Jozsa and Arne Dekker and Peer Briken",
year = "2014",
doi = "10.3109/15622975.2013.839052",
language = "English",
volume = "15",
pages = "472--478",
journal = "WORLD J BIOL PSYCHIA",
issn = "1562-2975",
publisher = "informa healthcare",
number = "6",

}

RIS

TY - JOUR

T1 - Which factors influence the appropriateness of testosterone-lowering medications for sex offenders? A survey among clinicians from German forensic-psychiatric institutions

AU - Turner, Daniel

AU - Basdekis-Jozsa, Raphaela

AU - Dekker, Arne

AU - Briken, Peer

PY - 2014

Y1 - 2014

N2 - Objectives. Although testosterone-lowering medications (TLM) are a frequently used addition to psychotherapy in sex offender treatment, discord still seems to exist amongst clinicians as to in which cases administering TLM is justified. The depo-Provera scale (DPS), which was published by Maletzky and Field (Aggress Violent Behav 2003;8:391), assesses the appropriateness of TLM administration in sex offender treatment. Methods. The DPS was sent to all forensic psychiatric institutions in Germany. The clinical directors of these institutions were asked to rate the importance of each item of the DPS on a six-point Likert scale. Results. Twenty-nine clinicians participated. The most important reason selected for the prescription of TLM for sex offender treatment was a "history of sexual offender treatment failure". The least important item was "deviant sexual interest, by plethysmograph or Abel Screen" (neither plethysmograph nor Abel Screen is used in Germany). Conclusions. Clinicians' attitudes towards the DPS correspond to the suggestions made in the current WSFBF-guidelines for the pharmacological treatment of sex offenders ( Thibaut et al. 2010 ; World J Biol Psychiatry 11:604-655). Use of the DPS could therefore contribute to a more structured approach towards helping clinicians come to a decision about whether or not to treat a sex offender with TLM.

AB - Objectives. Although testosterone-lowering medications (TLM) are a frequently used addition to psychotherapy in sex offender treatment, discord still seems to exist amongst clinicians as to in which cases administering TLM is justified. The depo-Provera scale (DPS), which was published by Maletzky and Field (Aggress Violent Behav 2003;8:391), assesses the appropriateness of TLM administration in sex offender treatment. Methods. The DPS was sent to all forensic psychiatric institutions in Germany. The clinical directors of these institutions were asked to rate the importance of each item of the DPS on a six-point Likert scale. Results. Twenty-nine clinicians participated. The most important reason selected for the prescription of TLM for sex offender treatment was a "history of sexual offender treatment failure". The least important item was "deviant sexual interest, by plethysmograph or Abel Screen" (neither plethysmograph nor Abel Screen is used in Germany). Conclusions. Clinicians' attitudes towards the DPS correspond to the suggestions made in the current WSFBF-guidelines for the pharmacological treatment of sex offenders ( Thibaut et al. 2010 ; World J Biol Psychiatry 11:604-655). Use of the DPS could therefore contribute to a more structured approach towards helping clinicians come to a decision about whether or not to treat a sex offender with TLM.

U2 - 10.3109/15622975.2013.839052

DO - 10.3109/15622975.2013.839052

M3 - SCORING: Journal article

C2 - 24219802

VL - 15

SP - 472

EP - 478

JO - WORLD J BIOL PSYCHIA

JF - WORLD J BIOL PSYCHIA

SN - 1562-2975

IS - 6

ER -